This page is part of the FHIR Specification (v5.0.0-ballot: R5 Ballot - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Clinical Genomics Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Patient |
Raw JSON (canonical form + also see JSON Format Specification)
GenomicStudy - Trio study - De novo mutation 2
{ "resourceType": "GenomicStudy", "id": "example-trio2", "text": { "status": "additional", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Prenatal Trio Whole Exome Sequencing testing to identify causal mutations of inherited diseases. Test order was for trio testing with three specimens i.e., proband, mother, father included. A comparator analysis-based trio report was to be generated for the proband; both parents had consented to receive reports on secondary findings.</div>" }, "identifier": [ { "use": "temp", "system": "http://www.somesystemabc.net/identifiers/genomicstudies", "value": "urn:uuid:1111-1111-1111-1113" } ], "status": { "coding": [ { "system": "http://hl7.org/fhir/genomicstudy-status", "code": "available", "display": "Available" } ] }, "type": [ { "coding": [ { "code": "trio", "display": "Trio-analysis" } ] } ], "subject": { "reference": "Patient/proband" }, "encounter": { "reference": "Encounter/denovoEncounter" }, "startDate": "2022-05-01", "basedOn": [ { "reference": "ServiceRequest/genomicSRProband" }, { "reference": "ServiceRequest/genomicSRMother" }, { "reference": "ServiceRequest/genomicSRFather" } ], "referrer": { "reference": "Practitioner/practitioner01" }, "interpreter": [ { "reference": "Practitioner/practitioner02" } ], "reason": [ { "concept": { "coding": [ { "system": "http://snomed.info/sct", "code": "67799006", "display": "Cystic fibrosis, prenatal detection (procedure) |" } ] } } ], "note": [ { "text": "This de novo mutation is urgent and important for establishing the treatment plan." } ], "description": "De novo mutation study of the patient. The Prenatal Trio Whole Exome Sequencing (Prenatal Trio WES) test is ordered by a physician and must be accompanied with a consent form and detailed clinical information. In general, the test is used when prenatal imaging detects an anomaly that strongly suggests that there is an underlying genetic etiology. Prenatal Trio WES is often considered only after fetal chromosome microarray analysis has been non-diagnostic.", "analysis": [ { "identifier": [ { "use": "temp", "system": "http://www.somesystemabc.net/identifiers/genomicAnalyses", "value": "urn:uuid:1111-1111-1111-1112" } ], "instantiatesUri": "https://pubmed.ncbi.nlm.nih.gov/33927380/", "title": "Maternal Sequence Variation Detection Using Next Generation Sequencing", "subject": { "reference": "Patient/mother" }, "specimen": [ { "reference": "Specimen/specimenMother" } ], "date": "2022-07-01T01:01:10-06:00", "note": [ { "text": "This is a next generation sequencing analysis of a mother of a proband." } ], "performer": [ { "actor": { "reference": "Practitioner/practitioner02" }, "role": { "coding": [ { "system": "http://terminology.hl7.org/3.1.0/CodeSystem-v3-ParticipationType.html", "code": "PRF", "display": "Performer" } ] } } ], "device": [ { "device": { "reference": "Device/NGS-device" } } ] }, { "identifier": [ { "use": "temp", "system": "http://www.somesystemabc.net/identifiers/genomicAnalyses", "value": "urn:uuid:1111-1111-1111-1113" } ], "instantiatesUri": "https://pubmed.ncbi.nlm.nih.gov/33927380/", "title": "Paternal Sequence Variation Detection Using Next Generation Sequencing", "subject": { "reference": "Patient/father" }, "specimen": [ { "reference": "Specimen/specimenFather" } ], "date": "2022-07-01T01:01:10-06:00", "note": [ { "text": "This is a next generation sequencing analysis of a father of a proband." } ], "performer": [ { "actor": { "reference": "Practitioner/practitioner02" }, "role": { "coding": [ { "system": "http://terminology.hl7.org/3.1.0/CodeSystem-v3-ParticipationType.html", "code": "PRF", "display": "Performer" } ] } } ], "device": [ { "device": { "reference": "Device/NGS-device" } } ] }, { "identifier": [ { "use": "temp", "system": "http://www.somesystemabc.net/identifiers/genomicAnalyses", "value": "urn:uuid:1111-1111-1111-1114" } ], "instantiatesUri": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885382/", "title": "De Novo Mutation Detection and Interpretation", "subject": { "reference": "Patient/proband" }, "date": "2022-07-01T03:01:10-06:00", "note": [ { "text": "This is a next generation sequencing analysis of the comparison analysis of proband and parents sequences." } ], "input": [ { "file": { "reference": "DocumentReference/genomicFileProband" }, "type": { "coding": [ { "system": "http://hl7.org/fhir/genomicstudy-dataformat", "code": "bam", "display": "BAM" } ] } }, { "file": { "reference": "DocumentReference/genomicFileMother" }, "type": { "coding": [ { "system": "http://hl7.org/fhir/genomicstudy-dataformat", "code": "bam", "display": "BAM" } ] } }, { "file": { "reference": "DocumentReference/genomicFileFather" }, "type": { "coding": [ { "system": "http://hl7.org/fhir/genomicstudy-dataformat", "code": "bam", "display": "BAM" } ] } } ], "output": [ { "file": { "reference": "DocumentReference/genomicFileGroupAsSubject" }, "type": { "coding": [ { "system": "http://hl7.org/fhir/genomicstudy-dataformat", "code": "vcf", "display": "VCF" } ] } } ], "performer": [ { "actor": { "reference": "Practitioner/practitioner02" }, "role": { "coding": [ { "system": "http://terminology.hl7.org/3.1.0/CodeSystem-v3-ParticipationType.html", "code": "PRF", "display": "Performer" } ] } } ], "device": [ { "device": { "reference": "Device/Triodenovo-SW" } } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-ballot generated on Sat, Sep 10, 2022 05:03+1000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change